LONDON — Prime Minister Boris Johnson had been expected to trumpet a rare success in the campaign against the coronavirus on Friday: news that Britain had vaccinated 5.4 million people. By the end of the day, it was overtaken by a tentative finding that a new variant of the virus may be deadlier than the original.

That possibility, raised by preliminary studies relying on small numbers of deaths in hard-hit hospitals, remains far from conclusive. But the prospect that the fast-spreading new variant, already known to be more contagious, could also be more lethal compounded fears that even with the arrival of vaccines, the pandemic will remain a severe threat for some time.

Government scientists said the early evidence suggests that the new variant, first detected late last year in Britain, could raise the risk of death by some 30%.

“In addition to spreading more quickly,” Mr. Johnson said at a Downing Street news conference, “it also now appears that there is some evidence that the new variant — the variant that was first identified in London and the southeast — may be associated with a higher degree of mortality.”

Advertise with us

The underlying evidence, outlined in a report published on Friday by a government scientific committee, was less emphatic than the prime minister, saying only that there was a “realistic possibility” that the new variant was deadlier and outlining a number of inescapable limitations in the data.

“I want to stress that there’s a lot of uncertainty around these numbers and we need more work to get a precise handle on it, but it obviously is a concern that this has an increase in mortality as well as an increase in transmissibility,” said the government’s chief scientific adviser, Sir Patrick Vallance.

Read More

For Mr. Johnson, who has struggled to find a silver lining in Britain’s response to the virus, it was not the first time that good news and bad went hand in hand. On Dec. 30, the government announced the authorization of a homegrown vaccine, developed by the University of Oxford and AstraZeneca, only to put much of the country into a stricter lockdown hours later because of a surge in infections.

Britain’s struggle with the pandemic has increasingly become a race between vaccinating the public and confronting mutations in the virus.

“2021 is going to be a cat-and-mouse game to see if we can vaccinate people quickly enough to stay ahead of the variants,” said Devi Sridhar, director of the global public health program at the University of Edinburgh.

Advertise with us

Outside experts said that the early claims of higher mortality were far from resolved.

For one, the studies were based on a small subset — roughly 8% — of total deaths in Britain, raising the possibility that the results “may therefore not be representative of the total population,” the report said.

For another, less than 3% of known infections in Britain have been fatal, so the new variant’s effect on mortality would have been measured in relatively small numbers, making it harder to pinpoint with certainty.

Moreover, the signs of higher mortality rates were at odds with evidence suggesting that people with the new variant were no more likely to be hospitalized than those infected with better-established ones.